LFB Biomanufacturing

LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Ales site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group

Biotechnology,monoclonal antibodies,recombinant proteins,diagnostics and biopharma,cell line development,mcb/wcb banking,upstream / downstream process development,fda approved,and process development

Lfb biomanufacturing operates in the Biotechnology research industry.

Lfb biomanufacturing's revenue is 11m - 100m

Lfb biomanufacturing has 51 - 200 employees.